Kronos Bio, Inc. (KRON) DCF Valuation
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Kronos Bio, Inc. (KRON) Bundle
Whether you’re an investor or analyst, this (KRON) DCF Calculator is your go-to resource for accurate valuation. Preloaded with real data from Kronos Bio, Inc., you can adjust forecasts and instantly observe the effects.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | .0 | .0 | .0 | .0 | 6.3 | 6.3 | 6.3 | 6.3 | 6.3 | 6.3 |
Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITDA | -15.5 | -79.7 | -147.0 | -128.7 | -121.8 | 3.8 | 3.8 | 3.8 | 3.8 | 3.8 |
EBITDA, % | 100 | 100 | 100 | 100 | -1937.5 | 60 | 60 | 60 | 60 | 60 |
Depreciation | .6 | 4.9 | 4.1 | 4.5 | 2.1 | 5.5 | 5.5 | 5.5 | 5.5 | 5.5 |
Depreciation, % | 100 | 100 | 100 | 100 | 33.97 | 86.79 | 86.79 | 86.79 | 86.79 | 86.79 |
EBIT | -16.1 | -84.6 | -151.1 | -133.2 | -124.0 | 3.8 | 3.8 | 3.8 | 3.8 | 3.8 |
EBIT, % | 100 | 100 | 100 | 100 | -1971.47 | 60 | 60 | 60 | 60 | 60 |
Total Cash | 92.2 | 462.1 | 339.5 | 247.9 | 173.0 | 6.3 | 6.3 | 6.3 | 6.3 | 6.3 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | .0 | .6 | .8 | .6 | .0 | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 |
Account Receivables, % | 100 | 100 | 100 | 100 | 0 | 80 | 80 | 80 | 80 | 80 |
Inventories | -.2 | -49.6 | -.8 | -10.3 | .0 | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 |
Inventories, % | 100 | 100 | 100 | 100 | 0 | 80 | 80 | 80 | 80 | 80 |
Accounts Payable | 1.5 | 4.6 | 1.0 | 5.0 | .9 | 5.2 | 5.2 | 5.2 | 5.2 | 5.2 |
Accounts Payable, % | 100 | 100 | 100 | 100 | 14.04 | 82.81 | 82.81 | 82.81 | 82.81 | 82.81 |
Capital Expenditure | -2.9 | -9.6 | -4.3 | -.6 | -.7 | -.1 | -.1 | -.1 | -.1 | -.1 |
Capital Expenditure, % | 100 | 100 | 100 | 100 | -10.8 | -2.16 | -2.16 | -2.16 | -2.16 | -2.16 |
Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITAT | -15.4 | -61.3 | -149.1 | -129.3 | -124.0 | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -16.1 | -14.1 | -201.8 | -111.6 | -136.4 | 3.1 | 8.8 | 8.8 | 8.8 | 8.8 |
WACC, % | 10.17 | 9.82 | 10.21 | 10.19 | 10.23 | 10.12 | 10.12 | 10.12 | 10.12 | 10.12 |
PV UFCF | ||||||||||
SUM PV UFCF | 28.1 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | 9 | |||||||||
Terminal Value | 111 | |||||||||
Present Terminal Value | 68 | |||||||||
Enterprise Value | 97 | |||||||||
Net Debt | -36 | |||||||||
Equity Value | 133 | |||||||||
Diluted Shares Outstanding, MM | 58 | |||||||||
Equity Value Per Share | 2.30 |
What You Will Get
- Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: Kronos Bio, Inc. (KRON) financial data pre-filled to kickstart your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
- Customizable and Professional: A sleek Excel model that adjusts to your valuation requirements.
- Built for Analysts and Investors: Perfect for assessing projections, validating strategies, and enhancing efficiency.
Key Features
- Comprehensive KRON Data: Pre-filled with Kronos Bio's historical performance metrics and future projections.
- Customizable Assumptions: Modify growth rates, profit margins, discount rates, tax implications, and capital investments.
- Interactive Valuation Framework: Automatic recalculations of Net Present Value (NPV) and intrinsic value based on your adjustments.
- Scenario Analysis: Develop multiple forecasting scenarios to explore various valuation possibilities.
- Intuitive User Interface: Clean, organized, and tailored for both experienced professionals and newcomers.
How It Works
- Step 1: Download the prebuilt Excel template featuring Kronos Bio, Inc.'s (KRON) data.
- Step 2: Navigate through the pre-filled sheets to grasp the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly see recalculated results, including Kronos Bio, Inc.'s (KRON) intrinsic value.
- Step 5: Make well-informed investment choices or create reports based on the outputs.
Why Choose This Calculator for Kronos Bio, Inc. (KRON)?
- User-Friendly Interface: Tailored for both novices and seasoned professionals.
- Customizable Variables: Adjust inputs effortlessly to suit your analytical needs.
- Real-Time Feedback: Monitor immediate changes to Kronos Bio’s valuation as you tweak inputs.
- Pre-Configured Data: Comes with Kronos Bio’s latest financial information for swift evaluations.
- Relied Upon by Experts: Employed by investors and analysts for making well-informed choices.
Who Should Use This Product?
- Professional Investors: Develop comprehensive and accurate valuation models for portfolio assessment of Kronos Bio, Inc. (KRON).
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
- Consultants and Advisors: Deliver precise valuation insights to clients regarding Kronos Bio, Inc. (KRON).
- Students and Educators: Utilize real-time data to enhance learning and practice in financial modeling.
- Biotech Enthusiasts: Gain insights into the valuation processes of biotech firms like Kronos Bio, Inc. (KRON).
What the Template Contains
- Pre-Filled DCF Model: Kronos Bio, Inc.’s (KRON) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Kronos Bio, Inc.’s (KRON) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.